Moreover, careful and comprehensive safety monitoring will be essential in any future clinical trials evaluating (-)-Vestitol, Salviolone, and especially their combination for AD treatment
Clinical experience and limited human data suggest daily doses between 200-1000 g, with 500 g representing a commonly reported effective dose, though these figures lack rigorous clinical trial validation
Research shows BPC-157 increases the stimulation of blood vessels through VEFG, upregulates early growth response genes, and increases nitric oxide through NOS3 stimulation.[ref] Here are a few of the studies in detail: A 2014 study outlined one mechanism of action, showing that BPC-157 enhances growth hormone receptors directly in the tendon, increasing growth hormone in the tendon
Skin starts to feel smoother and more hydrated
The incremental benefit over 10mg is measurable but more modest
Chen Y, Saari JT, Kang YJ